Shares of Kinross Gold (NYSE:KGC) have received an average rating of “Hold” from the seventeen analysts that are covering the company, American Banking News reports. Two analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and three have issued a buy recommendation on the company. On Thursday shares of Kinross Gold Corporation (NYSE:KGC) closed at $2.36. Company’s sales growth for last 5 years was 7.50%.
Advanced Cell Diagnostics, Inc. (ACD) a company that provides a sensitive and specific RNA hybridization technology, recently announced that Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is utilizing their leading technology to choose participants for a new Phase 2 clinical study to test the efficacy of the company’s drug candidate MM-121. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) in last trading activity remains unchanged to close at $11.22. Company weekly performance is -10.10% while its quarterly performance stands at 11.75%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is -10.24% away from its 52 week high.
On last trading day Silver Standard Resources Inc. (NASDAQ:SSRI) advanced 0.68% to close at $4.44. Its volatility for the week is 5.36% while volatility for the month is 5.43%. SSRI’s EPS growth for past 5 years was -42.80%. Silver Standard Resources Inc. (NASDAQ:SSRI) monthly performance is -26.97%.
On March 05, Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD), announced receipt of an award for a $134.5 million contract to deepen the Savannah Harbor federal shipping channel. The project involves deepening the entrance channel to a depth of 47 feet and represents the first step in deepening the 40 mile long shipping channel and harbor. Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) has 0.80% insider ownership while its institutional ownership stands at 93.80%. In last trading activity company’s stock closed at $5.90.
Sabine Royalty Trust (NYSE:SBR) begin trading ex-dividend on March 12, 2015. A cash dividend payment of $0.44414 per share is scheduled to be paid on March 30, 2015. On last trading day Sabine Royalty Trust (NYSE:SBR) fell -3.23% to close at $41.21. Its volatility for the week is 2.80% while volatility for the month is 3.04%. SBR’s sales growth for past 5 years was -7.80% and its EPS growth for past 5 years was -8.00%. Sabine Royalty Trust (NYSE:SBR) monthly performance is -3.07%.